Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Minoxidil and finasteride treat hair loss; more research needed for other options.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Certain hormone treatments can improve acne and related conditions in women.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Birth control pills can help reduce mild to moderate acne in women.

Start acne treatment early to prevent scarring, consider antibiotic resistance, use maintenance therapy, and manage side effects carefully.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Hydroxychloroquine helped improve scleromyxoedema in patients, but caused side effects in some.

Using 2% minoxidil for baldness treatment might cause vision distortion due to fluid build-up under the retina.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Hair loss treatment caused more hair loss in a man.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Use minoxidil for hair loss treatment; assess results after 6 months.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Finasteride effectively treats male pattern baldness, improving hair growth and density.